Search

Your search keyword '"Weyer, Karin"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Weyer, Karin" Remove constraint Author: "Weyer, Karin"
188 results on '"Weyer, Karin"'

Search Results

1. Digital health for the End TB Strategy: developing priority products and making them work

3. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

5. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

8. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

10. Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

16. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda

18. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

20. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions

21. Guidance for the Evaluation of Tuberculosis Diagnostics That Meet\ud the World Health Organization (WHO) Target Product Profiles: An\ud Introduction to WHO Process and Study Design Principles

22. Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study

23. Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests

24. Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis

25. Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis

27. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

28. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs

36. Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

37. The global response to rifampicin-resistant tuberculosis: Current situation and recent trends

43. Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies

44. Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance

45. Case study: South Africa

46. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Catalog

Books, media, physical & digital resources